參考文獻(xiàn)/References:
[1] 中國(guó)老年學(xué)學(xué)會(huì)骨質(zhì)疏松委員會(huì)骨質(zhì)疏松癥診斷標(biāo)準(zhǔn)學(xué)科組.中國(guó)人骨質(zhì)疏松癥診斷標(biāo)準(zhǔn)專(zhuān)家共識(shí)[J].中國(guó)骨質(zhì)疏松雜志,2014,20(9):1007-1010.
[2] 張智海,劉忠厚,石少輝,等.中國(guó)大陸地區(qū)以-2.5 SD為診斷的骨質(zhì)疏松癥發(fā)病率文獻(xiàn)回顧性研究[J].中國(guó)骨質(zhì)疏松雜志,2015,21(1):1-7.
[3] SI L,WINZENBERG T M,JIANG Q,et al.Projection of osteoporosis-related fractures and costs in China:2010-2050[J].Osteoporosis International,2015,26(7):1929-1937.
[4] 崔雷,劉偉,閆雷,等.文獻(xiàn)數(shù)據(jù)庫(kù)中書(shū)目信息共現(xiàn)挖掘系統(tǒng)的開(kāi)發(fā)[J].現(xiàn)代圖書(shū)情報(bào)技術(shù),2008,(8):70-75.
[5] 孫清蘭.高頻詞與低頻詞的界分及詞頻估算法[J].中國(guó)圖書(shū)館學(xué)報(bào),1992,(2):78-81.
[6] 中華醫(yī)學(xué)會(huì).臨床診療指南·骨質(zhì)疏松癥和骨礦鹽疾病分冊(cè)[M].北京:人民衛(wèi)生出版社,2006:1-7.
[7] 葛繼榮,鄭洪新,萬(wàn)小明,等.中醫(yī)藥防治原發(fā)性骨質(zhì)疏松癥專(zhuān)家共識(shí)(2015)[J].中國(guó)骨質(zhì)疏松雜志,2015,21(9):1023-1028.
[8] LIU G F,WANG Z Q,LIU L,et al.A network meta-analysis on the short-term efficacy and adverse events of different anti-osteoporosis drugs for the treatment of postmenopausal osteoporosis[J].J Cell Biochem,2018,119(6):4469-4481. 中醫(yī)正骨2019年8月第31卷第8期 J Trad Chin Orthop Trauma,2019,Vol.31,No.8(總639)(總640)中醫(yī)正骨2019年8月第31卷第8期 J Trad Chin Orthop Trauma,2019,Vol.31,No.8
[9] 李曉蘭,王慧文.疼痛護(hù)理方案對(duì)老年女性骨質(zhì)疏松腰背痛患者的影響[J].護(hù)理學(xué)雜志,2013,28(24):32-34.
[10] 胡周靜,彭旭玲,盧小玲,等.磁性護(hù)理服務(wù)在老年女性骨質(zhì)疏松性腰背痛患者康復(fù)護(hù)理中的應(yīng)用[J].實(shí)用臨床護(hù)理學(xué)電子雜志,2018,3(25):18-19.
[11] 王建民,李華東,王振東.溫針灸結(jié)合補(bǔ)陽(yáng)還五湯口服治療骨質(zhì)疏松性椎體壓縮骨折經(jīng)皮椎體后凸成形術(shù)后殘留痛[J].中醫(yī)正骨,2017,29(11):69-70.
[12] 張秀麗,隋顯玉,聶偉志.骨質(zhì)疏松性Colles骨折的中醫(yī)護(hù)理[J].中醫(yī)正骨,2018,30(4):76-77.
[13] 鄭揚(yáng)康,劉海全,侯蕾,等.原發(fā)性骨質(zhì)疏松疼痛癥的中醫(yī)藥治療新進(jìn)展[J].中國(guó)骨質(zhì)疏松雜志,2018,24(8):1080-1087.
[14] OTMAR R,REVENTLOW S D,NICHOLSON G C,et al.General medical practitioners’ knowledge and beliefs about osteoporosis and its investigation and management[J].Arch Osteoporos,2012,7:107-114.
[15] 郭小蘭,董博,姚潔.骨密度異常人群骨質(zhì)疏松相關(guān)知識(shí)了解情況和服務(wù)需求調(diào)查[J].護(hù)理研究,2018,32(4):608-610.
[16] 曹子璇,沈洪.骨質(zhì)疏松癥健康教育模式研究進(jìn)展[J].當(dāng)代護(hù)士,2019,26(5):14-16.
[17] 張銳,張邢煒,馮國(guó)和,等.骨質(zhì)疏松癥健康教育效果評(píng)價(jià)的研究進(jìn)展[J].護(hù)理學(xué)雜志,2014,29(24):80-82.
[18] 蘇佳燦,侯志勇,劉國(guó)輝,等.中國(guó)骨質(zhì)疏松性骨折圍手術(shù)期處理專(zhuān)家共識(shí)(2018)[J].中國(guó)臨床醫(yī)學(xué),2018,25(5):860-867.
[19] MEARS S C,KATES S L.A guide to improving the care of patients with fragility fractures,edition 2[J].Geriatr Orthop Surg Rehabil,2015,6(2):58-120.
[20] 于東方,王祥善,張華,等.經(jīng)皮椎體成形術(shù)后手術(shù)椎體再骨折的病因,治療及預(yù)防[J].中醫(yī)正骨,2018,30(10):69-73.
[21] 范振林,姜慧強(qiáng),劉紅英.骨質(zhì)疏松性股骨頸骨折術(shù)后早期康復(fù)干預(yù)的臨床分析[J].中國(guó)繼續(xù)醫(yī)學(xué)教育,2015,7(23):223-224.
[22] 張芬芳,錢(qián)繼紅,陳巧兒,等.加速康復(fù)外科用于椎體骨質(zhì)疏松性壓縮骨折經(jīng)皮椎體后凸成形術(shù)患者圍術(shù)期護(hù)理的可行性研究[J].護(hù)理與康復(fù),2014,13(6):523-525.
[23] MUNSHI R,KOCHHAR A,GARG V.Impact of dietary habits and physical activity on bone health among 40 to 60 year old females at risk of osteoporosis in India[J].Ecol Food Nutr,2015,54(5):470-492.
[24] HADJI P,PAPAIOANNOU N,GIELEN E,et al.Persistence,adherence,and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany,Austria,Greece,and Belgium:12-month results from a European non-interventional study[J].Osteoporosis Int,2015,26(10):2479-2489.
[25] 劉朝露,方茜.骨質(zhì)疏松性椎體壓縮骨折患者延續(xù)性護(hù)理的進(jìn)展[J].貴州醫(yī)藥,2018,42(5):557-559.
[26] MORDEN N E,SCHPERO W L,ZAHA R,et al.Overuse of short-interval bone densitometry:assessing rates of low-value care[J].Osteoporosis International,2014,25(9):2307-2311.
[27] ROZENBERG S,BODY J J,BRUYERE O,et al.Effects of dairy products consumption on health: benefits and beliefs—a commentary from the Belgian bone club and the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases[J].Calcif Tissue Int,2016,98(1):1-17.
[28] TSUKAHARA N.Osteoporosis liaison service and nutrition counseling and education[J].Clin Calcium,2017,27(9):1255-1263.
[29] 王曉慶,羅存珍,李鳳華,等.老年髖部骨折合并骨質(zhì)疏松出院病人的延續(xù)護(hù)理效果評(píng)價(jià)[J].護(hù)理研究,2016,30(4):438-440.
[30] STAMM T A,PIEBER K,CREVENNA R,et al.Impairment in the activities of daily living in older adults with and without osteoporosis,osteoarthritis and chronic back pain:a secondary analysis of population-based health survey data[J].BMC Musculoskelet Disord,2016,17:139.
[31] GUNENDI Z,EKER D,TECER D,et al.Is the word “osteoporosis” a reason for kinesiophobia?[J].Eur J Phys Rehabil Med,2018,54(5):671-675.
[32] 戴嬌,胡紅飛,吳清.基于老年綜合評(píng)估實(shí)施個(gè)性化護(hù)理干預(yù)對(duì)改善老年骨質(zhì)疏松癥患者生活質(zhì)量的效果分析[J].護(hù)理管理雜志,2015,15(12):893-895.
[33] 徐霞.整體護(hù)理在老年骨質(zhì)疏松性椎體壓縮性骨折圍術(shù)期的應(yīng)用價(jià)值[J].慢性病學(xué)雜志,2019,20(2):232-234.
相似文獻(xiàn)/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]韓艷,溫利平,劉娜,等.補(bǔ)腎活血方對(duì)去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補(bǔ)腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[3]李學(xué)朋,朱立國(guó).骨疏康膠囊對(duì)去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):12.
[4]陳冠軍,陳揚(yáng),莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[5]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):27.
[6]黃建華,黃建武,李慧輝,等.加味左歸丸對(duì)絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):19.
[7]項(xiàng)旻,楊虹,林愛(ài)菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):20.
[8]史曉林,李春雯,張志強(qiáng).弱陽(yáng)離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時(shí)間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標(biāo)志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):5.
[9]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機(jī)制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):21.
[10]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(08):16.